Clinical Trials on Large Vessel Occlusion in Netherlands

Total 535 results

Maatschap Cardiologie Zwolle
Diagram B.V.

Completed

Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

Coronary Artery Disease (CAD) | Peripheral Arterial Disease (PAD)

Netherlands
Svelte Medical Systems, Inc.

Completed

Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System (DIRECT II)

Coronary Artery Disease

Netherlands, France, Sweden, Germany, Switzerland, Belgium, Czechia
Novartis Pharmaceuticals

Completed

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Weill Medical College of Cornell University

Completed

Incident COronary EveNts Identified by Computed Tomography (ICONIC)

Atherosclerosis

Korea, Republic of, United States, Netherlands, Canada, Portugal, Germany, Austria, Italy
Boston Scientific Corporation

Active, not recruiting

Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery (EMINENT)

Vascular Diseases | Arteriosclerosis | Arterial Occlusive Diseases | Atherosclerosis

Germany, Ireland, Belgium, United Kingdom, France, Switzerland, Spain, Austria, Italy, Netherlands
Genzyme, a Sanofi Company

Completed

A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms (FIELD)

Fabry Disease

United States, Poland, Netherlands, Canada, Argentina, United Kingdom, Norway, Brazil, Czech Republic
Biotronik AG

Active, not recruiting

First in Men Study: BIOMAG-I

Coronary Artery Disease

Austria, Spain, Belgium, Poland, Sweden, Germany, Netherlands, Switzerland
Thorax Centrum Twente

Unknown

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands, Israel, Belgium
Zuyderland Medisch Centrum
Radboud University Medical Center; Maastricht University Medical Center; Brno... and other collaborators

Recruiting

FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease (SLIM)

Coronary Artery Disease | Percutaneous Coronary Intervention | NSTEMI - Non-ST Segment Elevation MI | Myocardial Revascularization | Fractional Flow Reserve, Myocardial

Czechia, Netherlands, Hungary
R&D Cardiologie
St. Antonius Hospital

Unknown

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. (WOEST 2)

Myocardial Infarction | Stroke | Bleeding | Acute Coronary Syndromes | Coronary Artery Diseases | Atrial Fibrillations | Heart Valve Prostheses

Belgium, Netherlands
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort B (ABSORB B)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Netherlands, Poland, France, Denmark, Australia, Switzerland, Belgium
Paradigm Spine

Completed

A Randomized Controlled Trial Comparing Surgical Decompression With an Interlaminar Implant in Patients With Intermittent Neurogenic Claudication Caused by Lumbar Stenosis (FELIX)

Intermittent Neurogenic Claudication (INC) as a Result of Spinal Stenosis

Netherlands
Radboud University Medical Center
UMC Utrecht; Catharina Ziekenhuis Eindhoven; Noordwest Ziekenhuisgroep; Medical... and other collaborators

Enrolling by invitation

The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT) (NL-CFT)

Coronary Vasospasm | Coronary Microvascular Dysfunction | Non-Obstructive Coronary Atherosclerosis

Netherlands
Sanofi

Completed

STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)

Coronary Atherosclerosis

Canada, United States, Italy, Spain, Poland, Netherlands, Belgium, France, Australia
National University of Ireland, Galway, Ireland

Recruiting

The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent (PIONEER-IV)

Coronary Artery Disease

Belgium, Netherlands, Ireland, United Kingdom, Spain
Volcano Corporation

Completed

Bifurcation Lesion Analysis and STenting / BLAST (BLAST)

Coronary Atherosclerosis

Netherlands, France, Latvia, United States, Denmark, Italy, Poland, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients (RESILIENT)

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Veryan Medical Ltd.

Unknown

Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D (MIMICS-3D)

Peripheral Arterial Disease

Netherlands, Sweden, Germany, Belgium
Academisch Medisch Centrum - Universiteit van Amsterdam...
Samsung Medical Center; Aarhus University Hospital; Seoul National University... and other collaborators

Completed

Inclusive Invasive Physiological Assessment in Angina Syndromes Registry (ILIAS Registry)

Coronary Artery Disease | Microvascular Coronary Artery Disease

Korea, Republic of, Denmark, Spain, Netherlands, Japan, United States, Italy
Kips Bay Medical, Inc.

Unknown

The eMESH 1 Feasibility Study (eMESH 1)

Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)

United States, United Kingdom, Czech Republic, Netherlands, France, Italy, Switzerland
Kite, A Gilead Company

Recruiting

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma (ZUMA-23)

High-risk Large B-cell Lymphoma (LBCL)

United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
Novartis Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180

Coronary Heart Disease

Germany, United States, Denmark, Israel, Netherlands
Shockwave Medical, Inc.

Completed

Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)

Coronary Artery Disease

Sweden, France, United Kingdom, Spain, Belgium, Denmark, Germany, Italy, Netherlands
TG Therapeutics, Inc.

Terminated

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL)

Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma

United States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
Amsterdam UMC, location VUmc

Recruiting

PeRcutaneous cOronary Intervention of Native Coronary arTery Versus Venous Bypass Graft in Patients With Prior CABG (PROCTOR)

Coronary Artery Disease

Belgium, Netherlands, United Kingdom, Germany, Poland
Novartis

Completed

Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)

Coronary Heart Disease

Netherlands, South Africa, United States, Belgium, Denmark, Israel, United Kingdom
OrbusNeich

Completed

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth

Coronary Artery Disease | Coronary Artery Stenosis

Netherlands, Belgium, United Kingdom, France, Germany, Austria
University of Malta
Università degli Studi dell'Insubria

Recruiting

DOAC in Unusual Site Venous Thrombosis (DUST)

Cerebral Vein Thrombosis | Renal Vein Thrombosis | Retinal Vein Thrombosis | Splanchnic Vein Thrombosis | Ovarian Vein Thrombosis

Thailand, Spain, United States, Italy, Slovenia, France, Israel, Canada, Malta, Netherlands
The University of Texas Health Science Center,...
Abbott Medical Devices

Completed

CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?) (CONTRAST)

Coronary Artery Disease

Korea, Republic of, Italy, Sweden, United States, Belgium, France, Netherlands, Portugal, United Kingdom
University Hospital, Saarland
B.Braun Vascular Systems, Berlin, Germany

Completed

DEBlue Stent vs Cypher Stent in the Treatment of Advanced Coronary Artery Disease (PEPCADIII)

Coronary Artery Disease

United Kingdom, Germany, Belgium, Spain, Czech Republic, France, Netherlands, Sweden
Central Clinical Hospital of the Russian Academy...
Ural State Medical University; De Haar Research Task Force; De Haar Research... and other collaborators

Terminated

Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging (REALITY)

Coronary Artery Disease | Alzheimer Disease | Contrast-induced Nephropathy | Coronary Atherosclerosis | Cerebrovascular Disease | Stable Chronic Angina | Chronic Coronary Insufficiency

Netherlands, Russian Federation, Estonia
Biotronik AG

Unknown

First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) (BIOSOLVE-II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Denmark, Germany, Brazil, Belgium, Netherlands, Singapore, Switzerland
GlaxoSmithKline

Completed

Integrated Biomarker And Imaging Study - 2

Atherosclerosis

Netherlands, Belgium, Germany, Czechia, France, Austria, Spain, Norway, Poland, Denmark, Switzerland
Genzyme, a Sanofi Company

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Fabry Disease

United States, France, Netherlands, Puerto Rico, United Kingdom
Fondazione C.N.R./Regione Toscana "G. Monasterio...
European Commission

Completed

Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease (EVINCI)

Ischemic Heart Disease

Netherlands, France, Finland, Germany, Italy, Poland, Spain, Switzerland, United Kingdom
European Society for Blood and Marrow Transplantation
Jazz Pharmaceuticals; Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide (VOD-DF)

Hepatic Veno-Occlusive Disease

Sweden, United Kingdom, Italy, Switzerland, Germany, Austria, France, Ireland, Israel, Netherlands
LimFlow SA

Active, not recruiting

PROMISE International

Critical Limb Ischemia

New Zealand, Singapore, Netherlands, Germany, Austria
Sanofi

Terminated

Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant (AUDITOR)

Arteriosclerosis | Obesity | Carotid Artery Plaque | Metabolic Syndrome X

United States, France, Canada, Netherlands, Spain, United Kingdom
REVA Medical, Inc.

Active, not recruiting

Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold (FANTOM II)

Coronary Artery Disease

Netherlands, Denmark, Poland, Germany, Australia, France, Belgium, Brazil
University Hospital Inselspital, Berne
European Cardiovascular Research Center

Completed

GLOBAL LEADERS Adjudication Sub-Study (GLASSY)

Coronary Artery Disease | Platelet-aggregation Inhibitors

Bulgaria, Switzerland, Austria, Belgium, Germany, Italy, Netherlands, Poland, United Kingdom
University Hospital, Basel, Switzerland

Completed

Ticagrelor Versus Clopidogrel in Carotid Artery Stenting (PRECISE-MRI)

Carotid Artery Stenosis

Germany, Switzerland, Belgium, Italy, Netherlands, United Kingdom
UMC Utrecht
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation (PRO-TAVI)

Coronary Artery Disease | Aortic Valve Stenosis | Valvular Heart Disease

Netherlands
Micell Technologies

Completed

Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-II)

Coronary Artery Disease

New Zealand, Netherlands, United Kingdom, France, Belgium, Sweden
Erik van der Hoeven
BASICS Study Group

Unknown

Basilar Artery International Cooperation Study (BASICS)

Stroke | Cerebrovascular Disorders | Basilar Artery Occlusion | Stroke of Basilar Artery | Basilar Artery Thrombosis | Basilar Artery Embolism

Netherlands, Germany, Brazil, Italy, Norway, Switzerland
AstraZeneca

Completed

12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe (GRAVITY)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease

Chile, Argentina, Brazil, United States, Colombia, Lithuania, Netherlands, Peru, Venezuela
Novartis Pharmaceuticals

Completed

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRYSTAL)

Central Retinal Vein Occlusion | Macular Edema

Greece, Hungary, Turkey, Australia, Austria, Netherlands, United Kingdom, Italy, Spain, Ireland, Portugal, Slovakia, Canada, Switzerland, Czech Republic, Poland, Denmark, Sweden
Biotronik AG

Unknown

Study of the Orsiro Drug Eluting Stent System (BIOFLOW-II)

Coronary Artery Disease

Latvia, Germany, Spain, Switzerland, Austria, France, Hungary, Netherlands
InflaRx GmbH

Completed

Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis. (IXchange)

Granulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)

Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
Hoffmann-La Roche

Completed

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Coronary Heart Disease

Switzerland, France, Germany, Netherlands, Austria, Italy, United Kingdom
Sanofi

Terminated

A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI

Microvascular Coronary Artery Disease

United States, Denmark, Korea, Republic of, Netherlands, Sweden

Clinical Trials on Large Vessel Occlusion in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations